Patent US5004461A successfully refreshed from Google Patents.
US5004461A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods for rendering plastics thromboresistant and product
Assignee: CAMPBELL RESEARCH Inc
•
Filing: 1989-03-23
•
Granted: 1991-04-02
•
Expires: 2009-03-23
Abstract
Abstract Provides antithrombotic agents which can be bonded to plastic to provide thromboresistant materials and a method for performing the bonding process. Further provides thromboresistant materials for medical devices used in contact with blood or blood products such as artificial hearts, heart lung machines, kidney dialysis machines, dialysis exchangers, pacemakers, vascular graft tubing, microporous membrane blood oxygenators, intra-aortic balloons, ultra-filtration membranes, blood bags, soft or hard tissue prostheses, cathaters, sutures, artificial organs, and the like.
Inventors
- 👤 Joseph E. Wilson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 19:22
CPC Classifications
A; A61; A61L; A61L33/00; A61L33/0076; A61L33/0088; A61L33/0082
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
79 words
A thromboresistant polymeric article for use in contact with blood or blood products, the polymeric article comprising: a polymeric body formed with at least one exposed surface for contacting blood or blood products, the polymeric body having bonded thereto an antithrombotic agent selected from the group consisting of 3-hydroxypyridine, 8-hydroxyquinoline, L-hydroxyproline, 2-(3,5-di-t-butyl-2-hydroxyphenyl)-5-chlorobenzotriazole, 1-hydroxybenzotriazole, and the compound which comprises an equiproportional mixture of dihydroergocornine methane sulfonate, dihydroergocristine methane sulfonate and α- and β-dihydroergocryptine methane sulfonate in the ratio of 1.5-2.5:1.0.
Claim 2
Dependent Claim
79 words
A thromboresistant polymeric article for use in contact with blood or blood products, the polymeric article comprising: a polymeric body formed with at least one exposed surface for contacting blood or blood products, the polymeric body having bonded thereto an antithrombotic agent selected from the group consisting of 3-hydroxypyridine, 8-hydroxyquinoline, L-hydroxyproline, 2-(3,5-di-t-butyl-2-hydroxyphenyl)-5-chlorobenzotriazole, 1-hydroxybenzotriazole, and the compound which comprises an equiproportional mixture of dihydroergocornine methane sulfonate, dihydroergocristine methane sulfonate and α- and β-dihydroergocryptine methane sulfonate in the ratio of 1.5-2.5:1.0.
Claim 3
Dependent Claim
33 words
The thromboresistant polymeric article of claim 1, wherein the polymer selected for forming the polymeric body is selected from the group consisting of polysilicone, polyethylene, polyamide, polyvinyl chloride, polyolefin, polyisoprene and butadiene/styrene copolymers.
Claim 4
Dependent Claim
46 words
The thromboresistant polymeric article of claim 2, wherein the polymeric body is selected from the group consisting of blood oxygenator tubing, blood oxygenator membrane, vascular graft tubing, catheters, sutures, blood bag, intra-aortic balloons, ultrafiltration membrane, soft tissue prothesis, hard tissue prothesis, artificial heart and artificial organs.
Claim 5
Dependent Claim
114 words
A thromboresistant polymeric article for use in contact with blood or blood products, the polymeric article comprising: a polymeric body having at least one exposed surface for contacting blood or blood products, the polymer being prepared by radiation grafting chains of an epoxypropyl acrylate thereto, followed by reaction of the epoxy groups present with the hydroxyl groups of an antithrombotic agent selected from the group consisting of 3-hydroxypyridine, 8-hydroxyquinoline, L-hydroxyproline, 2-(3,5-di-t-butyl-2-hydroxyphenyl)-5-chlorobenzotriazole, 1-hydroxybenzotriazole, and the compound which comprises an equiproportional mixture of dihydroergocornine methane sulfonate, dihydroergocristine methane sulfonate and α- and β-dihydroergocryptine methane sulfonate in the ratio of 1.5-2.5:1.0, resulting in covalent bonding of the antithrombotic agent to the exposed surface of the polymeric body.
Claim 6
Dependent Claim
114 words
A thromboresistant polymeric article for use in contact with blood or blood products, the polymeric article comprising: a polymeric body having at least one exposed surface for contacting blood or blood products, the polymer being prepared by radiation grafting chains of an epoxypropyl acrylate thereto, followed by reaction of the epoxy groups present with the hydroxyl groups of an antithrombotic agent selected from the group consisting of 3-hydroxypyridine, 8-hydroxyquinoline, L-hydroxyproline, 2-(3,5-di-t-butyl-2-hydroxyphenyl)-5-chlorobenzotriazole, 1-hydroxybenzotriazole, and the compound which comprises an equiproportional mixture of dihydroergocornine methane sulfonate, dihydroergocristine methane sulfonate and α- and β-dihydroergocryptine methane sulfonate in the ratio of 1.5-2.5:1.0, resulting in covalent bonding of the antithrombotic agent to the exposed surface of the polymeric body.
Claim 7
Independent Claim
157 words
A method of forming a thromboresistant polymeric article for use in contact with blood or blood products, the polymeric article being comprised of a polymeric body formed with at least one exposed surface for contacting blood or blood products, the method comprising the steps of: selecting an antithrombotic agent for permanent bonding to the polymeric article, the antithrombotic agent being selected from the group consisting of 3-hydroxypyridine, 8-hydroxyquinoline, L-hydroxyproline, 2-(3,5-di-t-butyl-2-hydroxyphenyl)-5-chlorobenzotriazole, 1-hydroxybenzotriazole, and the compound which comprises an equiproportional mixture of dihydroergocornine methane sulfonate, dihydroergocristine methane sulfonate and α- and β-dihydroergocryptine methane sulfonate in the ratio of 1.5-2.5:1.0; selecting a suitable monomer having a reactive linkage adapted to react with the antithrombotic agent to chemically bond the antithrombotic agent to the polymeric article; grafting the monomer having the reactive linkage to the polymeric article; and reacting the antithrombotic agent with the reactive linkages of the grafted monomer to thereby covalently bond the antithrombotic agent to the polymeric article.
Claim 8
Independent Claim
157 words
A method of forming a thromboresistant polymeric article for use in contact with blood or blood products, the polymeric article being comprised of a polymeric body formed with at least one exposed surface for contacting blood or blood products, the method comprising the steps of: selecting an antithrombotic agent for permanent bonding to the polymeric article, the antithrombotic agent being selected from the group consisting of 3-hydroxypyridine, 8-hydroxyquinoline, L-hydroxyproline, 2-(3,5-di-t-butyl-2-hydroxyphenyl)-5-chlorobenzotriazole, 1-hydroxybenzotriazole, and the compound which comprises an equiproportional mixture of dihydroergocornine methane sulfonate, dihydroergocristine methane sulfonate and α- and β-dihydroergocryptine methane sulfonate in the ratio of 1.5-2.5:1.0; selecting a suitable monomer having a reactive linkage adapted to react with the antithrombotic agent to chemically bond the antithrombotic agent to the polymeric article; grafting the monomer having the reactive linkage to the polymeric article; and reacting the antithrombotic agent with the reactive linkages of the grafted monomer to thereby covalently bond the antithrombotic agent to the polymeric article.
Claim 9
Independent Claim
174 words
A method of forming a thromboresistant polymeric article for use in contact with blood or blood products, the polymeric article being comprised of a polymeric body formed with at least one exposed surface for contacting blood or blood products, the method comprising the steps of: selecting an antithrombotic agent for permanent bonding to the polymeric article, the antithrombotic agent being selected from the group consisting of 3-hydroxypyridine, 8-hydroxyquinoline, L-hydroxyproline, 2-(3,5-di-t-butyl-2-hydroxyphenyl)-5-chlorobenzotriazole, 1-hydroxybenzotriazole, and the compound which comprises an equiproportional mixture of dihydroergocornine methane sulfonate, dihydroergocristine methane sulfonate and α- and β-dihydroergocryptine methane sulfonate in the ratio of 1.5-2.5:1.0, the antithrombotic agent being characterized as having reactive hydroxyl groups; radiation grafting chains of epoxypropyl acrylate onto the polymeric article, the epoxypropyl acrylate being characterized as having reactive epoxy linkages adapted to react with the reactive hydroxyl groups of the antithrombotic agent to thereby chemically bond the antithrombotic agent to the polymeric article; reacting the antithrombotic agent with the reactive linkages of the grafted epoxypropyl acrylate to thereby covalently bond the antithrombotic agent to the polymeric article.
Claim 10
Independent Claim
174 words
A method of forming a thromboresistant polymeric article for use in contact with blood or blood products, the polymeric article being comprised of a polymeric body formed with at least one exposed surface for contacting blood or blood products, the method comprising the steps of: selecting an antithrombotic agent for permanent bonding to the polymeric article, the antithrombotic agent being selected from the group consisting of 3-hydroxypyridine, 8-hydroxyquinoline, L-hydroxyproline, 2-(3,5-di-t-butyl-2-hydroxyphenyl)-5-chlorobenzotriazole, 1-hydroxybenzotriazole, and the compound which comprises an equiproportional mixture of dihydroergocornine methane sulfonate, dihydroergocristine methane sulfonate and α- and β-dihydroergocryptine methane sulfonate in the ratio of 1.5-2.5:1.0, the antithrombotic agent being characterized as having reactive hydroxyl groups; radiation grafting chains of epoxypropyl acrylate onto the polymeric article, the epoxypropyl acrylate being characterized as having reactive epoxy linkages adapted to react with the reactive hydroxyl groups of the antithrombotic agent to thereby chemically bond the antithrombotic agent to the polymeric article; reacting the antithrombotic agent with the reactive linkages of the grafted epoxypropyl acrylate to thereby covalently bond the antithrombotic agent to the polymeric article.
Claim 11
Dependent Claim
37 words
The method of forming a thromboresistant polymeric article of claim 6, wherein the polymer selected for forming the polymeric body is selected from the group consisting of polysilicone, polyethylene, polyamide, polyvinyl chloride, polyolefin, polyisoprene and butadiene/styrene copolymers.
Claim 12
Dependent Claim
50 words
The method of forming a thromboresistant polymeric article of claim 7, wherein the polymeric body is selected from the group consisting of blood oxygenator tubing, blood oxygenator membrane, vascular graft tubing, catheters, sutures, blood bags, intra-aortic balloons, ultrafiltration membrane, soft tissue prothesis, hard tissue prothesis, artificial heart and artificial organs.
References Cited (Backward Citations)
US3625741A
Cited
US3566874A
Cited
US3861396A
Cited
US4642104A
Cited
US4451568A
Cited
US4554317A
Cited
US4542169A
Cited
US4605564A
Cited
US4581028A
Cited
US4612337A
Cited
US4863444A
Cited
US4950256A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-04-01 | 1994-10-01 | 1995-04-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-04-01 | 1998-10-01 | 1999-04-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-04-01 | 2002-10-01 | 2003-04-02 | $7700.00 | Window Closed / Lapsed |